M4MM
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban
LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...
Calgary Authorizes Cannabis Sales at Adults-Only Events
LOS ANGELES- Calgary City Council has approved amendments to the Business Licence Bylaw, permitting licensed cannabis retailers to operate temporary sales at adults-only events, such as festivals and outdoor shows. This decision aligns the city's ...
Christina Lake Cannabis Closes First Tranche of Non-Brokered Private Placement
LOS ANGELES- Christina Lake Cannabis Corp. has completed the first tranche of its non-brokered private placement, issuing 22,778,211 units at a price of CAD $0.05 per unit, totaling approximately CAD $1.14 million. Each unit comprises ...
The Role of Government Relations in Cannabis Industry Success
NEW YORK — In highly regulated industries, success depends not only on how well a business operates, but also on how well it fits within the rules set by government. This is especially true in ...
Government Relations at The Core
NEW YORK — In industries where business depends on regulation—such as cannabis, infrastructure, or fintech—navigating the policy environment is foundational. Laws, budget priorities, administrative procedures, and even decisions by local councils directly affect where companies ...
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban
LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...
VA to Explore Psychedelics for PTSD and Depression
LOS ANGELES- In a groundbreaking move, the Department of Veterans Affairs (VA) is funding research into the therapeutic potential of psychedelics for treating mental health conditions like post-traumatic stress disorder (PTSD) and depression in veterans. ...
Maine’s Booming Cannabis Market Faces Challenges Amid Falling Prices
LOS ANGELES— Maine's regulated adult-use cannabis industry recorded over $200 million in sales in 2023, marking a significant 36% increase from the previous year. Despite these robust figures, released by the state Office of Cannabis ...
DEA Clarifies Legality of Psychedelic Mushroom Spores, Highlighting Regulatory Complexities
WASHINGTON, D.C. — The U.S. Drug Enforcement Administration (DEA) recently provided a crucial clarification on the legal status of psychedelic mushroom spores. According to a statement from Terrence Boos, Chief of the DEA's Drug and ...
West Virginia Eyes Cannabis Legalization in Fight Against Fentanyl Crisis
NEW YORK— As West Virginia's legislative session unfolds, the topics of cannabis legalization and the fentanyl crisis are taking center stage. Senate President Craig Blair, speaking at a press event on January 5, indicated that ...
Over 2.3 Million Cannabis Convictions Pardoned in U.S. Since 2018
LOS ANGELES- In a significant move towards criminal justice reform, U.S. state courts have pardoned or expunged over 2.3 million cannabis-related convictions since 2018, with about half a million cases resolved in the last year ...
Ohio Governor Advocates for Ban on Intoxicating Hemp Products Amid Cannabis Regulation Efforts
LOS ANGELES— Ohio Governor Mike DeWine has urged state legislators to ban hemp-derived cannabinoids, including delta-8 THC, citing potential risks to children. The call for legislative action comes as Ohio prepares to navigate the complexities ...
Florida Bill Proposes THC Limits in Cannabis Amid Legalization Debates
LOS ANGELES- In a move that could significantly impact the cannabis industry in Florida, State Representative Ralph Massullo has introduced a bill proposing to limit the potency of THC in cannabis products. This legislative effort ...
Canopy Growth Secures US$30 Million in Private Placement to Bolster Liquidity and Reduce Debt
NEW YORK – In a significant move to strengthen its financial position, Canopy Growth Corporation, a leading North American cannabis and consumer packaged goods company, has announced a major private placement offering. On January 9, ...
Tilray Brands Q2 Report Amid Cannabis and Beverage Expansion
LOS ANGELES- Tilray Brands, Inc., Cannabis and consumer packaged goods industries, has announced its financial results for the second quarter of fiscal year 2024, ended November 30, 2023. The company has reported a record net ...
Germany’s Path to Cannabis Legalization: A Potential Boon for Global Markets and U.S. Investors
BERLIN — Germany's recent announcement to legalize recreational cannabis use for adults has set the stage for what is expected to be a multi-billion dollar market, sparking significant interest from investors, companies, and countries worldwide, ...
MAPS Public Benefit Corporation Secures Over $100 Million for Groundbreaking PTSD Therapy
LOS ANGELES- MAPS Public Benefit Corporation a key player in mental healthcare innovation, has announced an oversubscribed Series A financing round, raising over $100 million. This significant funding milestone, which includes conversion of previously issued ...
Wisconsin Navigates the Complex Path Toward Cannabis Legalization Amid Political Divide
LOS ANGELES- Wisconsin’s journey toward cannabis legalization is unfolding against a backdrop of political complexities, with Governor Tony Evers, a Democrat, indicating openness to a Republican-led medical cannabis legalization plan. This stance emerges as broader ...
Record Destruction of Cannabis in Canada Points to Market Adjustments and Consumer Trends
NEW YORK- In a striking development, Canadian cannabis operators have destroyed a record amount of legal cannabis in 2022 and the first half of 2023, as per data from Health Canada. This action highlights the ...
4Front Ventures Corp. Initiates Comprehensive Financial and Leadership Revamp
LOS ANGELES- In a pivotal development, 4Front Ventures Corp., a multi-state cannabis operator, has embarked on a transformative journey, reshaping its financial landscape and ushering in a new era of leadership. This strategic shift is ...
Incannex Healthcare Concludes Phase 2 Trial of Psilocybin Therapy for Anxiety Disorder, Awaiting FDA IND Application
LOS ANGELES- Incannex Healthcare Inc., a pharmaceutical company in the development of medicinal cannabinoid and psychedelic medicine therapies, has recently completed a significant milestone in its PsiGAD-1 clinical trial. This Phase 2 study, focused on ...
